Vivid Genomics

Vivid Genomics uses machine learning and disease biology to develop genetic-based tests to identify patient variation across multiple characteristics in dementia. The first set of tests are focused on Alzheimer’s disease; with the information from these tests, pharma companies can better stratify clinical-trial participants and improve the probability of their trial’s success.